Handing Wyeth a setback in a patent infringement suit over its antidepressant Effexor XR, a federal judge says the pharmaceutical manufacturer can’t claim its out-of-court settlements in earlier cases are confidential.

Magistrate Judge Douglas Arpert in Trenton, N.J., held Tuesday that the discovery request was reasonable and relevant to defense of the suit, Wyeth v. Orgenus Pharma Inc., 09-cv-03235.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]